A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy

Abstract

Human pluripotent stem cell (hPSC)-based therapies offer promise but pose potential risks due to culture-acquired genetic variants, some of which have been linked with cancer. An international workshop addressed these concerns, highlighting the need for improved strategies to stratify variants and chart a path toward definitive guidelines in hPSC-based therapy.

Journal details

Journal Cell Stem Cell
Volume 32
Issue number 4
Pages 508-512
Available online
Publication date